Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
cytarabin 100 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 100 mg/ml injektionsvæske, opløsning, hætteglas a 20 ml |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 20 mg/ml injektionsvæske, opløsning, hætteglas a 25 ml |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 1 g pulver til injektionsvæske, opløsning, hætteglas |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 20 mg/ml injektionsvæske, opløsning 5ml |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 100 mg/ml injektionsvæske, opløsning, hætteglas a 1 ml |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 100 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 100 mg pulver til injektionsvæske, opløsning, hætteglas |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
Product containing precisely cytarabine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
liposomalt cytarabin 50 mg/5 ml injektionsvæske, hætteglas a 5 ml |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 500 mg pulver til injektionsvæske, hætteglas |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 1 g/pulver til injektionsvæske, hætteglas |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 2 g/pulver til injektionsvæske, hætteglas |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
Product containing precisely cytarabine 1 gram/10 milliliter conventional release solution for injection vial |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
Product containing precisely cytarabine 100 milligram/1 milliliter conventional release solution for injection vial |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
Product containing precisely cytarabine 2 gram/20 milliliter conventional release solution for injection vial |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
Product containing precisely cytarabine 500 milligram/5 milliliter conventional release solution for injection vial |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
Product containing precisely cytarabine 500 milligram/25 milliliter conventional release solution for injection vial |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
Product containing only cytarabine in parenteral dose form (medicinal product form) |
Is a |
True |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
Product containing cytarabine and daunorubicin in parenteral dose form (medicinal product form) |
Is a |
True |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|